Josef S. Smolen, MD, led the way for outcomes measures and a scientifically based training program
Search results for: musculoskeletal
Rehabilitation and Myositis
Physical therapy to manage inflammatory muscle disease
Myositis Mysteries
Why isn’t my myositis patient getting better?
ARHP in 2008
As I begin my presidency, let me thank you—the ARHP membership—for allowing me to steer this organization through the 2008 year. As a physical therapist in clinical practice for more than 25 years, I have experienced the challenges of treating people with arthritis and rheumatic diseases. For the past 13 years, I have served the ARHP in various capacities and, as my personal involvement in the ARHP has grown, my knowledge of this premier rheumatology organization has also expanded.
Is Your Office Lab Up to Par?
Rheumatology practices with laboratory testing facilities in their offices can offer important benefits to patients and physicians. During their care of patients with musculoskeletal and rheumatic diseases, rheumatologists may order many tests, including erythrocyte sedimentation rate, synovial fluid analysis, complete blood count, fecal occult test, and urinalysis. While the prompt receipt of test results and the capability to evaluate specimens in the office directly improves efficiency, it is important to remember that offices must be certified to perform laboratory testing, particularly high-complexity tests such as the analysis of synovial fluids.
Rheumatology’s Mentor
Halsted R. Holman, MD, couples a stellar career with a knack for helping others achieve their potential
Innovative Educational Programs for Rheumatology APNs and PAs
Arthritis and other rheumatic diseases affect more than 46 million adults and 300,000 children in the United States. With the aging of the U.S. population, the number of adults with rheumatic disease is expected to increase to 67 million by 2030.1 While the demand for rheumatology services is increasing, the supply of practicing rheumatologists is diminishing. The ACR Rheumatology Workforce Study (published earlier this year) predicts that there will be little or no increase in the number of practicing rheumatologists, resulting in a critical shortage of rheumatologists by 2020.
Enhanced Opportunities at the 2007 Meeting
The AMPC is using more translational components as a way of increasing the basic scientist’s interaction with clinicians, he explains. In keeping with this, the meeting will offer sessions on osteoclasts, implications for the development and treatment of osteoarthritis, T-cell subsets, and a year in review – all of which will be of interest to both the clinician and the basic researcher.
A Better Family Plan
How to minimize the risks of pregnancy for women with SLE
Disappearing Dollars
What’s happening to federal research funding in rheumatology?